Congenital heart disease reproduction: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Congenital heart disease}} {{CMG}}; '''Associate Editor-In-Chief:''' Priyamvada Singh, MBBS [mailto:psingh@perfuse.org] '''Assistant Editor-I..." |
m Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu) |
||
| Line 2: | Line 2: | ||
{{Congenital heart disease}} | {{Congenital heart disease}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh@perfuse.org] '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@ | {{CMG}}; '''Associate Editor-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh@perfuse.org] '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@elon.edu] | ||
==Overview== | ==Overview== | ||
Revision as of 14:44, 1 November 2012
|
Congenital heart disease Microchapters |
|
Differentiating Congenital heart disease from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Congenital heart disease reproduction On the Web |
|
American Roentgen Ray Society Images of Congenital heart disease reproduction |
|
Risk calculators and risk factors for Congenital heart disease reproduction |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Priyamvada Singh, MBBS [2] Assistant Editor-In-Chief: Kristin Feeney, B.S. [3]
Overview
Reproduction
ACC/AHA 2008 Guidelines: Recommendations for Pregnancy and Contraception - Adults with Congenital Heart Disease.(DO NOT EDIT)[1]
| Class I |
| "1. Patients with CHD should have consultation with an ACHD expert before they plan to become pregnant to develop a plan for management of labor and the postpartum period that includes consideration of the appropriate response to potential complications. This care plan should be made available to all providers. (Level of Evidence: C) " |
| "2. Patients with intracardiac right-to-left shunting should have fastidious care of intravenous lines to avoid paradoxical air embolus. (Level of Evidence: C) " |
| "3. Prepregnancy counseling is recommended for women receiving chronic anticoagulation with warfarin to enable them to make an informed decision about maternal and fetal risks. (Vitale et al., 1999; Sareli et al., 1989; van Driel et al., 2001) (Level of Evidence: B) " |
| Class III (Harm) |
| "1. The estrogen-containing oral contraceptive pill is not recommended for ACHD patients at risk of thromboembolism, such as those with cyanosis related to an intracardiac shunt, severe PAH, or Fontan repair. (Level of Evidence: C) " |
| Class IIa |
| "1. Meticulous prophylaxis for deep venous thrombosis, including early ambulation and compression stockings, can be useful for all patients with intracardiac right-to-left shunt. Subcutaneous heparin or low-molecular-weight heparin is reasonable for prolonged bed rest. Full anticoagulation can be useful for the high-risk patient. (Level of Evidence: C) " |
References
- ↑ Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.